We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DXPE:NASDAQDXP Enterprises, Inc. Analysis

Data as of 2026-06-27 - not real-time

$163.36

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

DXP Enterprises is trading at $163.36, comfortably above its 20‑day ($162.12) and 50‑day ($159.20) simple moving averages, indicating a short‑term bullish bias. The RSI sits at 52, suggesting neutral momentum, while the MACD histogram is marginally negative and the signal line is labeled bearish, hinting at a possible near‑term pullback. Volume has been increasing, supporting the price advance, but the stock’s 30‑day volatility of 43% and a computed beta of 1.83 point to heightened market sensitivity. On the fundamentals side, revenue grew 9.5% YoY to $2.06 B with solid gross (31.7%) and operating (8.3%) margins, though net profit margin is modest at 4.3% and Q1 earnings missed consensus by 2.3%. The trailing P/E of 30.6 is marginally below the industry average of 31.5, while the forward P/E of 21.8 signals expected earnings acceleration. However, the discounted cash‑flow fair value of $18.14 is dramatically lower than the current price, yielding a -3% downside estimate, flagging the stock as overvalued in absolute terms. Recent news highlights the revenue beat but a slight earnings miss, and the share price has underperformed the broader market in the past few sessions. Overall, the company shows resilient growth and a stable cash position, but the combination of high volatility, elevated beta, and overvaluation metrics tempers enthusiasm. Investors should weigh the strong top‑line growth against the valuation gap and market‑risk profile before making a move.
In the near term, the technical picture is mixed and the stock’s price correction risk is evident, whereas the medium‑term outlook benefits from improving earnings visibility and a reasonable forward P/E. Long‑term prospects remain linked to the cyclical nature of industrial distribution, making a cautious, value‑oriented stance prudent.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above short‑term moving averages but MACD turning bearish
  • Recent earnings miss and stock underperformance vs market
  • High short‑term volatility and beta

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth of 9.5% and improving forward earnings outlook
  • Forward P/E of 21.8 indicating reasonable valuation relative to earnings growth
  • Increasing volume and bullish trend direction

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Cyclical exposure of industrial distribution sector
  • Sustained cash generation but modest net margins
  • Elevated valuation gap versus DCF fair value

Key Metrics & Analysis

Financial Health

Revenue Growth9.50%
Profit Margin4.27%
P/E Ratio30.6
ROE18.41%
ROA7.30%
Debt/Equity176.11
P/B Ratio4.9
Op. Cash Flow$120.9M
Free Cash Flow$48.7M
Industry P/E31.5

Technical Analysis

TrendBullish
RSI52.1
Support$141.00
Resistance$175.13
MA 20$162.12
MA 50$159.20
MA 200$131.84
MACDBearish
VolumeIncreasing
Fear & Greed Index88.55

Valuation

Fair Value$18.14
Target Price$158.50
Upside/Downside-2.98%
GradeOvervalued
TypeBlend

Risk Assessment

Beta1.83
Volatility43.05%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.